TUS-PHARMA: The net profit for the third quarter was 2.3495 million yuan, a year-on-year increase of 146.43%

TUS-PHARMA announced that its revenue for the third quarter was 82.3783 million yuan, a year-on-year increase of 18.40%; net profit was 2.3495 million yuan, a year-on-year increase of 146.43%. Revenue for the first three quarters was 225 million yuan, a year-on-year increase of 3.97%; net profit loss was 14.8206 million yuan, a year-on-year decrease of 47.91%

The change of control of TUS-PHARMA has been completed, and Hunan Sailuoxian has become the controlling shareholder

TUS-PHARMA has completed the change of controlling rights, with Hunan Sailoxian becoming the new controlling shareholder. On July 15, 2025, the 58,606,962 shares held by TUS-PHARMA were successfully auctioned to Hunan Sailoxian, and the transfer of property rights and stock registration was completed on August 6. The company held an extraordinary general meeting to elect Jiang Xin as the chairman and president. Hunan Sailoxian holds 24.47%, and Hengyang Hongxiang State-owned Investment Group holds 19.11%. As of the announcement date, the change of control has been completed, and the business is stable

TUS-PHARMA: Elect Jiang Lin as Chairman

TUS-PHARMA announced that the company will hold the seventh meeting of the tenth board of directors on September 23, 2025, to elect Mr. Jiang Xin as the chairman of the tenth board of directors, with a term starting from the date of the board's approval until the end of the tenth board's term. At the same time, Mr. Jiang Xin will be appointed as the company's president, and Mr. Qiao Xuefeng will be appointed as the company's vice president. Mr. Jiang Xin does not directly hold shares in the company but holds shares indirectly through the shareholder Hunan Sailoxian, being the actual controller of Hunan Sailoxian. Mr. Qiao Xuefeng holds 7,200 shares of the company

TUS-PHARMA plans to change its name to "GuHan Health Industry Group Co., Ltd."

According to the Zhitong Finance APP, TUS-PHARMA announced that the company's board of directors agreed to change the company's name to "GuHan Health Industry Group Co., Ltd." and simultaneously revise the relevant provisions of the Articles of Association. After the name change is completed, the company will apply to the Shenzhen Stock Exchange for a change in the stock abbreviation, while the company's stock code will remain unchanged

TUS-PHARMA: Chairman Jiao Qisen resigns